Cargando…

Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment

Detalles Bibliográficos
Autores principales: Furune, Satoshi, Kondo, Chiaki, Takano, Yuko, Shimokata, Tomoya, Sugishita, Mihoko, Mitsuma, Ayako, Maeda, Osamu, Ando, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787004/
https://www.ncbi.nlm.nih.gov/pubmed/35129544
http://dx.doi.org/10.1007/s13691-021-00517-8
_version_ 1784639265278263296
author Furune, Satoshi
Kondo, Chiaki
Takano, Yuko
Shimokata, Tomoya
Sugishita, Mihoko
Mitsuma, Ayako
Maeda, Osamu
Ando, Yuichi
author_facet Furune, Satoshi
Kondo, Chiaki
Takano, Yuko
Shimokata, Tomoya
Sugishita, Mihoko
Mitsuma, Ayako
Maeda, Osamu
Ando, Yuichi
author_sort Furune, Satoshi
collection PubMed
description
format Online
Article
Text
id pubmed-8787004
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-87870042022-02-02 Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment Furune, Satoshi Kondo, Chiaki Takano, Yuko Shimokata, Tomoya Sugishita, Mihoko Mitsuma, Ayako Maeda, Osamu Ando, Yuichi Int Cancer Conf J Correction Springer Singapore 2021-10-26 /pmc/articles/PMC8787004/ /pubmed/35129544 http://dx.doi.org/10.1007/s13691-021-00517-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Furune, Satoshi
Kondo, Chiaki
Takano, Yuko
Shimokata, Tomoya
Sugishita, Mihoko
Mitsuma, Ayako
Maeda, Osamu
Ando, Yuichi
Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
title Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
title_full Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
title_fullStr Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
title_full_unstemmed Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
title_short Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
title_sort correction to: vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787004/
https://www.ncbi.nlm.nih.gov/pubmed/35129544
http://dx.doi.org/10.1007/s13691-021-00517-8
work_keys_str_mv AT furunesatoshi correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment
AT kondochiaki correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment
AT takanoyuko correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment
AT shimokatatomoya correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment
AT sugishitamihoko correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment
AT mitsumaayako correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment
AT maedaosamu correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment
AT andoyuichi correctiontovitiligoandtumorresponseinapatientwithamelanoticmelanomaundergoingnivolumabtreatment